Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Tempest Therapeutics, Inc. (TPST) had Weighted-Average Shares Outstanding (Diluted) of 10.93M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-27.70M |
|
-- |
|
-- |
|
$27.72M |
|
$-27.72M |
|
$0.02M |
|
$-27.70M |
|
$-27.70M |
|
$-27.70M |
|
$-27.70M |
|
$-27.70M |
|
$-27.70M |
|
$-27.72M |
|
$-27.66M |
|
10.93M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
10.93M |
$-2.53 |
|
$-2.53 |
|
| Balance Sheet Financials | |
$2.45M |
|
$0.55M |
|
$8.30M |
|
$10.75M |
|
$3.31M |
|
-- |
|
$6.62M |
|
$9.93M |
|
$0.82M |
|
$0.82M |
|
$0.82M |
|
14.34M |
|
| Cash Flow Statement Financials | |
$-7.60M |
|
-- |
|
$1.70M |
|
$8.15M |
|
$2.25M |
|
$-5.90M |
|
$0.23M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.74 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-7.60M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-3369.26% |
|
-3369.34% |
|
-257.69% |
|
-3369.34% |
|
$0.06 |
|
$-0.69 |
|
$-0.69 |
|